In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people died as a result of the disease, according to the National Cancer Institute. These numbers are staggering. The challenge for clinicians and researchers is... Read more
Cofactor’s kit will be used to characterize the immune responses generated in reaction to treatment with an investigational personalized cancer vaccine. Source: Cofactor Genomics Inks Pilot Study Deal for Immune Profiling Kit Evaluation | GenomeWeb Read more
–Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions– Cofactor Genomics, a Source: Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical... Read more
In addition to celebrating DNA day, my team celebrated a milestone: Cofactor completed 1,000 runs on one of our sequencing platforms. What does 1,000 runs look like? It represents 400 billion individual sequencing reads and more than 50 trillion individual bases. Each... Read more
